{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:28:51Z","timestamp":1761514131815,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clbc.2023.06.006","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T21:04:01Z","timestamp":1687295041000},"page":"681-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Breast Cancer and Mediastinal Hodgkin's Lymphomas: Multidisciplinary Discussion"],"prefix":"10.1016","volume":"23","author":[{"given":"Ruben","family":"Touati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Reyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clbc.2023.06.006_bib0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0360-3016(98)00217-X","article-title":"Second cancer among long-term survivors from Hodgkin's disease","volume":"42","author":"Nyandoto","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.clbc.2023.06.006_bib0002","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199603213341201","article-title":"Breast cancer and other second neoplasms after childhood Hodgkin's disease","volume":"334","author":"Bhatia","year":"1996","journal-title":"N Engl J Med"},{"issue":"7919","key":"10.1016\/j.clbc.2023.06.006_bib0003","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(75)92576-3","article-title":"Letter: second malignancies complicating Hodgkin's disease in remission","volume":"1","author":"Canellos","year":"1975","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clbc.2023.06.006_bib0004","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11912-010-0123-2","article-title":"State-of-the-art issues in Hodgkin's lymphoma survivorship","volume":"12","author":"Baxi","year":"2010","journal-title":"Curr Oncol Rep"},{"issue":"17","key":"10.1016\/j.clbc.2023.06.006_bib0005","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1517\/14656566.2010.515979","article-title":"Hodgkin's lymphoma therapy: past, present, and future","volume":"11","author":"Rathore","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"26","key":"10.1016\/j.clbc.2023.06.006_bib0006","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin's lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.clbc.2023.06.006_bib0007","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/cncr.28747","article-title":"Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging","volume":"120","author":"Tieu","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2023.06.006_bib0008","first-page":"75","article-title":"American cancer society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.clbc.2023.06.006_bib0009","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ijrobp.2020.03.019","article-title":"Involved site radiation therapy in adult lymphomas: an overview of international lymphoma radiation oncology group guidelines","volume":"107","author":"Wirth","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2407-12-197","article-title":"Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis","volume":"12","author":"Ibrahim","year":"2012","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.clbc.2023.06.006_bib0011","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.2016.70.9709","article-title":"Risk of second cancer in Hodgkin lymphoma survivors and influence of family history","volume":"35","author":"Sud","year":"2017","journal-title":"J Clin Oncol."},{"issue":"18_suppl","key":"10.1016\/j.clbc.2023.06.006_bib0012","doi-asserted-by":"crossref","first-page":"CRA9513","DOI":"10.1200\/jco.2012.30.18_suppl.cra9513","article-title":"New insights into the risk of breast cancer in childhood cancer survivors treated with chest radiation: a report from the childhood cancer survivor study (CCSS) and the women's environmental cancer and radiation epidemiology (WECARE) study","volume":"30","author":"Moskowitz","year":"2012","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.clbc.2023.06.006_bib0013","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1016\/S1470-2045(13)70303-6","article-title":"Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the international late effects of childhood cancer guideline harmonization group","volume":"14","author":"Mulder","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.06.006_bib0014","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","article-title":"Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood","volume":"18","author":"van Leeuwen","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.06.006_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2000.18.3.498","article-title":"Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment","volume":"18","author":"Swerdlow","year":"2000","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2023.06.006_bib0016","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2006.09.0936","article-title":"Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma","volume":"25","author":"Hodgson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0017","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2014.12.009","article-title":"Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the international lymphoma radiation oncology group","volume":"92","author":"Maraldo","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.clbc.2023.06.006_bib0018","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clbc.2023.06.006_bib0019","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V106.11.814.814","article-title":"Comparison of three radiation dose levels after EBVP regimen in favorable supradiaphragmatic clinical stages (CS) I-II Hodgkin's lymphoma (HL): preliminary results of the EORTC-GELA H9-F trial","volume":"106","author":"Eghbali","year":"2005","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.clbc.2023.06.006_bib0020","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1200\/JCO.21.02407","article-title":"Limited, but not eliminated, excess long-term morbidity in stage I-IIA Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine and limited-field radiotherapy","volume":"40","author":"Lagerl\u00f6f","year":"2022","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2023.06.006_bib0021","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clbc.2013.06.001","article-title":"Prophylactic mastectomy: a treatment alternative for Hodgkin survivors?","volume":"13","author":"Boucher","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2023.06.006_bib0022","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1245\/s10434-022-11947-w","article-title":"Surgical management and contralateral breast cancer risk in women with history of radiation therapy for hodgkin lymphoma: results from a population-based cohort","volume":"29","author":"Eisenberg","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2023.06.006_bib0023","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","article-title":"Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Senkus","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2023.06.006_bib0024","unstructured":"Official Statements. ASBrS. Available at: https:\/\/www.breastsurgeons.org\/resources\/statements., Accessed November 24, 2022"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1748-717X-4-19","article-title":"Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis","volume":"4","author":"El-Din","year":"2009","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.06.006_bib0026","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1200\/JCO.2000.18.4.765","article-title":"Management of breast cancer after Hodgkin's disease","volume":"18","author":"Wolden","year":"2000","journal-title":"J Clin Oncol."},{"issue":"3","key":"10.1016\/j.clbc.2023.06.006_bib0027","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-8140(01)00337-1","article-title":"Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases","volume":"59","author":"Cutuli","year":"2001","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.06.006_bib0028","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.ijrobp.2011.03.013","article-title":"Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option","volume":"82","author":"Haberer","year":"2012","journal-title":"Int J Radiat Oncol Bio Phys"},{"issue":"2","key":"10.1016\/j.clbc.2023.06.006_bib0029","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdl399","article-title":"Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors","volume":"18","author":"Sanna","year":"2007","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00000421-200102000-00005","article-title":"Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma","volume":"24","author":"Deutsch","year":"2001","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2023.06.006_bib0031","doi-asserted-by":"crossref","first-page":"R828","DOI":"10.1186\/bcr1310","article-title":"A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT)","volume":"7","author":"Intra","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"7","key":"10.1016\/j.clbc.2023.06.006_bib0032","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ncponc1135","article-title":"Lumpectomy and partial breast irradiation for early-stage breast cancer following mantle irradiation for Hodgkin's lymphoma","volume":"5","author":"Alm El-Din","year":"2008","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.06.006_bib0033","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/COC.0b013e318180c880","article-title":"Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin's disease","volume":"32","author":"Chadha","year":"2009","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.06.006_bib0034","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10549-009-0421-2","article-title":"Breast-conserving therapy after previous irradiation for lymphoma","volume":"124","author":"Nguyen","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2023.06.006_bib0035","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0960-9776(11)70304-6","article-title":"Local therapy for breast cancer in malignant lymphoma survivors","volume":"20","author":"Intra","year":"2011","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0036","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13566-012-0073-4","article-title":"Patterns of relapse and risk for new malignancies following partial breast re-irradiation","volume":"2","author":"Chadha","year":"2013","journal-title":"J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0037","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13566-016-0262-7","article-title":"Comparison of treatment modalities for breast cancer arising in Hodgkin's lymphoma survivors","volume":"6","author":"Burt","year":"2017","journal-title":"J Radiat Oncol"},{"issue":"13","key":"10.1016\/j.clbc.2023.06.006_bib0038","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.ejca.2015.05.024","article-title":"Management of breast cancer after Hodgkin's lymphoma and paediatric cancer","volume":"51","author":"Terenziani","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2023.06.006_bib0039","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fonc.2017.00175","article-title":"Evaluation of partial breast reirradiation with intraoperative radiotherapy after prior thoracic radiation: a single-institution report of outcomes and toxicity","volume":"7","author":"Chin","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.clbc.2023.06.006_bib0040","series-title":"Breast Cancer: Innovations in Research and Management","first-page":"399","article-title":"Breast Cancer in Lymphoma Survivors","author":"Intra","year":"2017"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0041","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.critrevonc.2011.01.005","article-title":"Breast cancer occurred after Hodgkin's disease: clinico-pathological features, treatments and outcome: analysis of 214 cases","volume":"81","author":"Cutuli","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.clbc.2023.06.006_bib0042","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ijrobp.2012.01.040","article-title":"Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients","volume":"84","author":"Lymberis","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0043","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2008.11.005","article-title":"Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy","volume":"75","author":"Kirova","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0044","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijrobp.2009.01.053","article-title":"The lateral decubitus breast boost: description, rationale, and efficacy","volume":"76","author":"Ludwig","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clbc.2023.06.006_bib0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.radonc.2013.10.038","article-title":"Whole breast radiotherapy in the lateral decubitus position: a dosimetric and clinical solution to decrease the doses to the organs at risk (OAR)","volume":"110","author":"Kirova","year":"2014","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.06.006_bib0046","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/srao.2000.6593","article-title":"Tissue tolerance to reirradiation","volume":"10","author":"Nieder","year":"2000","journal-title":"Semin in Radiat Oncol"},{"key":"10.1016\/j.clbc.2023.06.006_bib0047","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0960-9776(16)30015-7","article-title":"Focalized intraoperative irradiation after conservative surgery for early-stage breast cancer","volume":"10","author":"Veronesi","year":"2001","journal-title":"The Breast"},{"issue":"5","key":"10.1016\/j.clbc.2023.06.006_bib0048","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00000421-199310000-00009","article-title":"Intraoperative radiotherapy. A positive view","volume":"16","author":"Calvo","year":"1993","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.06.006_bib0049","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1524-4741.2001.007002091.x","article-title":"Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer","volume":"7","author":"Krishnan","year":"2001","journal-title":"Breast J"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<33::AID-JSO6>3.0.CO;2-O","article-title":"Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy","volume":"70","author":"Vicini","year":"1999","journal-title":"J Surg Oncol"},{"issue":"13","key":"10.1016\/j.clbc.2023.06.006_bib0051","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2023.06.006_bib0052","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0960-9776(03)00156-5","article-title":"Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer","volume":"12","author":"Orecchia","year":"2003","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0053","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1748-717X-5-90","article-title":"Accelerated partial breast irradiation (APBI): a review of available techniques","volume":"5","author":"Njeh","year":"2010","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.06.006_bib0054","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0360-3016(01)01547-4","article-title":"The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy","volume":"50","author":"Baglan","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clbc.2023.06.006_bib0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1096-9098(199708)65:4<263::AID-JSO7>3.0.CO;2-3","article-title":"Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study","volume":"65","author":"Perera","year":"1997","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.06.006_bib0056","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2017.05.004","article-title":"Evidence-based review on the use of proton therapy in lymphoma from the particle therapy cooperative group (PTCOG) lymphoma subcommittee","volume":"99","author":"Tseng","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"10.1016\/j.clbc.2023.06.006_bib0057","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.3390\/cancers13153746","article-title":"Current situation of proton therapy for hodgkin lymphoma: from expectations to evidence","volume":"13","author":"Loap","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clbc.2023.06.006_bib0058","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canrad.2015.11.002","article-title":"Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy","volume":"20","author":"Horn","year":"2016","journal-title":"Cancer Radiother"},{"issue":"2","key":"10.1016\/j.clbc.2023.06.006_bib0059","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.radonc.2013.08.040","article-title":"Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions","volume":"108","author":"Mulliez","year":"2013","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.06.006_bib0060","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0360-3016(03)00723-5","article-title":"Three-dimensional photon dosimetry: a comparison of treatment of the intact breast in the supine and prone position","volume":"57","author":"Griem","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clbc.2023.06.006_bib0061","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2010.05.014","article-title":"Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry","volume":"96","author":"Kirby","year":"2010","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0062","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijrobp.2008.05.017","article-title":"Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment","volume":"72","author":"Hama","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"11","key":"10.1016\/j.clbc.2023.06.006_bib0063","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.clon.2015.06.007","article-title":"Cardiac side-effects from breast cancer radiotherapy","volume":"27","author":"Taylor","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"5","key":"10.1016\/j.clbc.2023.06.006_bib0064","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/SAP.0000000000002087","article-title":"Outcomes following breast reconstruction in patients with prior mantle radiation for treatment of Hodgkin's lymphoma","volume":"84","author":"Freniere","year":"2020","journal-title":"Ann Plast Surg"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00006534-200201000-00017","article-title":"Breast reconstruction using tissue expanders and implants in Hodgkin's patients with prior mantle irradiation","volume":"109","author":"Bacilious","year":"2002","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.clbc.2023.06.006_bib0066","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bjps.2021.08.003","article-title":"Combined skin-sparing mastectomy and immediate implant-based breast reconstruction: Outcome following mantle field irradiation versus outcome following whole-breast irradiation","volume":"75","author":"van Huizum","year":"2022","journal-title":"J Plast Reconstr Aesthet Surg"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:25:58Z","timestamp":1761513958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1526820923001635"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.06.006","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast Cancer and Mediastinal Hodgkin's Lymphomas: Multidisciplinary Discussion","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}